CD274 and small cell lung carcinoma: When combined with anti-PD-L1 antibody, WEE1 targeting demonstrates a significant antitumor effect in multiple SCLC models, suggesting that this combination may be valuable clinically to overcome primary and adaptive resistance to ICB in SCLC.